Cardiometabolic Online Series (Multiple Modules)
The latest evidence-based data addressing cardiometabolic diseases is presented in this online series.
Lipid Management Program
The Lipid Management Program at Miami Cardiac & Vascular Institute is a resource to help patients who require additional expertise to assess their cardiovascular risk and to manage their lipids. Typically, primary care physicians, endocrinologists and cardiologists assess and monitor lipids in patients. Our Lipid Management Program is designed to help patients that are unable to tolerate traditional lipid management therapies or that have complex disorders that require specialized care. We work collaboratively with your physician to help you reach your lipid goal in a safe and well-tolerated way.
The Lipid Management Program is covered under insurance. Referrals from physicians are recommended but not required. Patients who are interested in the program are invited to call 786-204-4499 for more information or to set up a consultation with a cardiovascular lipid specialist.
Target Audience
Baptist Health Medical Group Physicians, Baptist Health Quality Network Physicians, Primary Care Physicians, Internal Medicine Physicians, Cardiologists, Interventional Cardiologists, Family Practitioners, Endocrinologists, Obstetricians, Gynecologists, Physician Assistants, Dietitians, Nurses, Advanced Practice Registered Nurses, Pharmacists and all other healthcare professionals who care for patients with cardiometabolic diseases.
![]() | Theodore Feldman, M.D., FACC, FACP Medical Director, Center for Healthcare Advancement & Outcomes Baptist Health South Florida Medical Director, Prevention and Community Health Miami Cardiac & Vascular Institute Head of Cardiology & Clinical Associate Professor of Medicine FIU Wertheim College of Medicine Theodore Feldman, M.D., has indicated that he is on the speakers bureau for Novartis, Regeneron, Sanofi, Amgen, Boehringer Ingelheim and Novo Nordisk and is a consultant for Merck. |
![]() | CONFERENCE DIRECTOR Jonathan Fialkow, M.D., FACC, FAHA Cardiovascular Disease, Clinical Lipidologist Deputy Medical Director Chief of Cardiology Miami Cardiac & Vascular Institute Chief Population Health Officer Baptist Health South Florida Jonathan Fialkow, M.D., FACC, FAHA, has indicated that he is on the speakers bureau for Amgen and Amarin. |
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
See individual course pages for applicable credits and accreditations.